In vitro upregulation of B7 molecules expression by rhGM-CSF and rhIL-4 in myeloid leukemia cells

Qinfen Chen,Yanhui Xie,Zhensheng Dai,Tong Chen,Xiaowu Xu,Hong Xie,Yi Xie -
2001-01-01
Abstract:Purpose: To investigate the upregulation efficacy of rhGM-CSF and rhIL-4 in B7 costimulatory molecules expression on myeloid leukemia cells. Methods: MNCs were isolated from peripheral blood of acute and chronic myeloid leukemia patients, co-cultured with rhGM-CSF and rhIL-4 for 7 - 10 days. Before and after cytokines induced, B7-1 (CD80) and B7-2 (CD86) expression was assayed by flow cytometry. Results: Before induced, average B7-1 and B7-2 expression was (1.20 ± 0.79)% and (3.69 ± 2.23)%, respectively. After 7 days cytokines co-cultured, average epression was (8.98 ± 2.98)% and (22.24 ± 5.07)%, respectively. And after 10 days co-cultured, the expression was (6.58 ± 3.11) % and (14.90 ± 5.73)%, respectively. Conclusions: B7 costimulatory molecules expression on the myeloid leukemia cell surface was defective. These costimulatory molecules on the myeloid leukemia cells can be upregulated by a oombination of rhGM-CSF and rhIL-4.
What problem does this paper attempt to address?